Literature DB >> 10683347

Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks.

A Mauriello1, G Sangiorgi, G Palmieri, R Virmani, D R Holmes, R S Schwartz, R Pistolese, A Ippoliti, L G Spagnoli.   

Abstract

BACKGROUND: Epidemiological studies have demonstrated that hyperfibrinogenemia is an independent risk factor for cerebrovascular atherosclerosis. However, the underlying mechanisms are poorly understood. We studied whether hyperfibrinogenemia could modify the histological composition of atherosclerotic plaque and precipitate carotid thrombosis resulting from rupture of the plaque. METHODS AND
RESULTS: We studied the histological composition of 71 carotid atherosclerotic plaques from patients who had undergone surgical endarterectomy after a first episode of transient ischemic attack. Patients were divided into 3 groups corresponding to the tertiles of plasma fibrinogen values. Hypercholesterolemia, hypertriglyceridemia, hypertension, diabetes, and smoking habit were also assessed. At the histological analysis, plaques of patients in the highest tertile of fibrinogen (>407 mg/dL) were characterized by a high incidence of thrombosis (66.7% of cases) compared with plaques of subjects in the lower (21.7%) (P=0.002) and middle (29. 2%) (P=0.009) tertiles. Plaque rupture was significantly associated with high fibrinogen levels (54.2%, P=0.003). Multivariate logistic regression indicated that hyperfibrinogenemia was an independent risk factor for a decrease in cap thickness (P=0.0005), macrophage foam cell infiltration of the cap (P=0.003), and thrombosis (P=0. 003). When the presence of other risk factors was accounted for, hyperfibrinogenemia remained an independent predictor of carotid thrombosis with an odds ratio of 5.83, compared with other risk factors.
CONCLUSIONS: The results of the present study add to the evidence that hyperfibrinogenemia, independently of other risk factors, is associated with a specific histological composition of carotid atherosclerotic plaques that predisposes them to rupture and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683347     DOI: 10.1161/01.cir.101.7.744

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Thrombophilia in ischemic stroke subtypes: implications for treatment.

Authors:  Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Diffusion-weighted magnetic resonance imaging in carotid angioplasty and stenting with balloon embolic protection devices.

Authors:  Fumio Asakura; Kenji Kawaguchi; Hiroshi Sakaida; Naoki Toma; Satoshi Matsushima; Keita Kuraishi; Hiroshi Tanemura; Yoichi Miura; Masayuki Maeda; Waro Taki
Journal:  Neuroradiology       Date:  2006-01-17       Impact factor: 2.804

Review 3.  Blood biomarkers of ischemic stroke.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 4.  Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus.

Authors:  Kazuyuki Yahagi; Frank D Kolodgie; Christoph Lutter; Hiroyoshi Mori; Maria E Romero; Aloke V Finn; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-01       Impact factor: 8.311

5.  Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke.

Authors:  Saami K Yazdani; Marc Vorpahl; Elena Ladich; Renu Virmani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-06

Review 6.  Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-08-05

7.  Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT).

Authors:  Ronnie Ramadan; Saurabh S Dhawan; José Nilo G Binongo; Ayman Alkhoder; Dean P Jones; John N Oshinski; Arshed A Quyyumi
Journal:  Am Heart J       Date:  2016-01-18       Impact factor: 4.749

Review 8.  The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack.

Authors:  Matthew B Jensen; Marcus R Chacon; Justin A Sattin; Aitziber Aleu; Patrick D Lyden
Journal:  Neurologist       Date:  2008-07       Impact factor: 1.398

9.  High-resolution multicontrast-weighted MR imaging from human carotid endarterectomy specimens to assess carotid plaque components.

Authors:  Sebastiano Fabiano; Stefano Mancino; Matteo Stefanini; Marcello Chiocchi; Alessandro Mauriello; Luigi Giusto Spagnoli; Giovanni Simonetti
Journal:  Eur Radiol       Date:  2008-08-27       Impact factor: 5.315

10.  Atherosclerotic plaque volume and composition in symptomatic carotid arteries assessed with multidetector CT angiography; relationship with severity of stenosis and cardiovascular risk factors.

Authors:  S Rozie; T T de Weert; C de Monyé; P J Homburg; H L J Tanghe; D W J Dippel; A van der Lugt
Journal:  Eur Radiol       Date:  2009-04-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.